Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy. (2023)
Attributed to:
Development of intracellular VNARs as novel tools to dissect intracellular biological processes
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2023.1296567
PubMed Identifier: 38116078
Publication URI: http://europepmc.org/abstract/MED/38116078
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812